WDR79 Antibodies

Santa Cruz Biotechnology delivers a wide array of WDR79 monoclonal antibodies for research focused on understanding WDR79 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WDR79, also known as WD repeat domain 79, plays key roles in signal transduction and gene regulation. WDR79 maintains cellular homeostasis and influences various biological pathways, making it an important focus for cellular biology and disease mechanism studies. Research on WDR79 continues to reveal its significance in cancer and neurodegenerative disorders. Investigating WDR79 expression and interactions helps advance understanding of disease progression and potential therapeutic approaches. Detailed characterization of WDR79 cellular distribution and binding partners provides valuable insights into its biological functions. Exploring WDR79's role in different tissue types and developmental stages enhances knowledge of its regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful discoveries about WDR79's impact on human health and disease.